This Year’s Overseer and HAA Director Candidates

The official nominees for 2019 are announced.

This spring, alumni can vote for new Harvard Overseers and Harvard Alumni Association (HAA) elected directors. Ballots will be sent by April 1; completed ballots must be received by 5 p.m. EDT on May 21 to be counted. All holders of Harvard degrees, except Corporation members and officers of instruction and government, are entitled to vote for Overseer candidates. The election for HAA directors is open to all Harvard degree-holders.

Candidates for Overseer may also be nominated by petition. Eligible voters may go to elections.harvard.edu for more information. (The deadline for all petitions was February 1.)

The HAA Nominating Committee has proposed the following candidates in 2019.*

 

For Overseer (six-year term):

Danguole Spakevicius Altman ’81, Houston. Founder, Vapogenix Inc.

Alice Hm Chen, M.P.H. ’01, Berkeley. Chief medical officer and deputy director, San Francisco Health Network 

Scott C. Collins ’87, J.D. ’90, Boston. Managing director and COO, Summit Partners

Janet Echelman ’87, Brookline, Massachusetts. Visual artist, Studio Echelman 

Vivian Hunt ’89, M.B.A. ’95, D.B.E., London. Managing partner, U.K. and Ireland, McKinsey & Company, Inc.

Tyler Jacks ’83, Cambridge. Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

John B. King Jr. ’96 (’95), Washington, D.C. President and CEO, The Education Trust

Reshma Saujani, M.P.P. ’99, New York City. Founder and CEO, Girls Who Code

Ryan Wise, Ed.L.D. ’13, Des Moines. Director, Iowa Department of Education

 

For elected director (three-year term): 

George C. Alex ’81, Cohasset, Massachusetts. CEO, Twin Oaks Capital

Bryan C. Barnhill II ’08, Detroit. City manager, City Solutions, Ford Smart Mobility 

Ethel Billie Branch ’01, J.D.-M.P.P ’08, Window Rock, Arizona. Attorney general, The Navajo Nation

Salomé Cisnal de Ugarte, LL.M. ’94, Brussels. Managing partner, Hogan Lovells

Adrienne E. Dominguez ’90, Dallas. Partner, intellectual property, Thompson & Knight LLP

Michael J. Gaw ’90, Alexandria, Virginia. Assistant director, division of trading and markets, U.S. Securities and Exchange Commission

Christina Lewis ’02, New York City. Founder and CEO, All Star Code

Zandile H. Moyo ’00, Indian Springs, Alabama. Consultant, strategy and financial advisory services

Derek C.M. van Bever, M.B.A. ’88, M.Div. ’11, Cambridge. Senior lecturer and director of the Forum for Growth & Innovation, Harvard Business School

 

*The HAA Nominating Committee has nominated nine candidates for Overseer, rather than the usual eight. This reflects an additional vacancy on the board created by the departure of James Hildreth ’79, who has stepped down in light of other professional obligations.

You might also like

Harvard Divinity School Sets New Priorities

After two years of turmoil, Dean Marla Frederick describes a more pluralistic future for the institution’s culture and curriculum.

From Jellyfish to Digital Hearts

How Harvard researchers are helping to build a virtual model of the human heart

Yale Chief Will Lead Harvard Police Department

Anthony Campbell will take up his new post in January.

Most popular

See Their Faces

Confronting “some of the most challenging images in the history of photography”

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Martin Nowak Sanctioned for Jeffrey Epstein Involvement

The Faculty of Arts and Sciences announces disciplinary actions.

Explore More From Current Issue

A person walks across a street lined with historic buildings and a clock tower in the background.

Harvard In the News

A legal victory against Trump, hazing in the Harvard-Radcliffe Orchestra, and kicking off a Crimson football season with style

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.